GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ayr Wellness Inc (OTCPK:AYRWF) » Definitions » Debt-to-EBITDA

Ayr Wellness (Ayr Wellness) Debt-to-EBITDA : 12.25 (As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Ayr Wellness Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Ayr Wellness's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $42.7 Mil. Ayr Wellness's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $555.1 Mil. Ayr Wellness's annualized EBITDA for the quarter that ended in Dec. 2023 was $48.8 Mil. Ayr Wellness's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was 12.25.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Ayr Wellness's Debt-to-EBITDA or its related term are showing as below:

AYRWF' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -8.59   Med: 5.52   Max: 11.08
Current: 7.01

During the past 6 years, the highest Debt-to-EBITDA Ratio of Ayr Wellness was 11.08. The lowest was -8.59. And the median was 5.52.

AYRWF's Debt-to-EBITDA is ranked worse than
87.86% of 659 companies
in the Drug Manufacturers industry
Industry Median: 1.66 vs AYRWF: 7.01

Ayr Wellness Debt-to-EBITDA Historical Data

The historical data trend for Ayr Wellness's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ayr Wellness Debt-to-EBITDA Chart

Ayr Wellness Annual Data
Trend Sep18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
Get a 7-Day Free Trial -0.40 11.08 5.52 -8.59 7.07

Ayr Wellness Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.58 4.63 10.59 5.50 12.25

Competitive Comparison of Ayr Wellness's Debt-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Ayr Wellness's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ayr Wellness's Debt-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ayr Wellness's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Ayr Wellness's Debt-to-EBITDA falls into.



Ayr Wellness Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Ayr Wellness's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(42.717 + 555.052) / 84.596
=7.07

Ayr Wellness's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(42.717 + 555.052) / 48.788
=12.25

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2023) EBITDA data.


Ayr Wellness  (OTCPK:AYRWF) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Ayr Wellness Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Ayr Wellness's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Ayr Wellness (Ayr Wellness) Business Description

Traded in Other Exchanges
Address
2601 South Bayshore Drive, Suite 900, Miami, FL, USA, 33133
Ayr Wellness Inc is a vertically integrated, U.S. multi-state cannabis operator, focused on delivering quality cannabis products and customer experience throughout its footprint. The company is focused on superior cultivation to grow superior branded cannabis products.